iVEAcare Launched $27.5 Million Series A Funding from Leading Medtech Investors
On April 24, 2024, iVEAcare, announced the closure of a $27.5 million Series A financing. The financing was led by Vensana Capital, which was joined by Treo Ventures, Hatteras Venture Partners, and an undisclosed strategic partner. iVEAcare is the third spin-off from NuXcel, a medical device accelerator and backed by Treo Ventures.
Alongside securing funding, the company revealed Todd Kerkow's new role as President and CEO. Kerkow brings extensive expertise in the medical device sector, boasting almost thirty years of experience with companies like Guidant, Cameron Health, Boston Sci...